Repeated intermittent amphetamine enhances efflux of dopamine through the dopamine transporter in rat basal ganglia and through the norepinephrine transporter in rat pheochromocytoma PC12 cells. Extracellular Ca 2ϩ is required for the detection of this enhancement in the rat. In this study, we examined the role of Ca 2ϩ and Ca 2ϩ channels in the enhanced amphetamine-induced dopamine efflux that develops in PC12 cells following repeated intermittent amphetamine. Repeated pretreatment of PC12 cells with 1 M amphetamine followed by a drug-free period increased amphetamine-induced efflux of dopamine compared with controls. The enhancement in amphetamine-induced dopamine efflux depended upon the presence of extracellular Ca 2ϩ and was inhibited by the blockade of N-type and L-type Ca 2ϩ channels. The enhanced dopamine efflux was not altered by tetanus toxin or reserpine, treatments that abrogate synaptic vesicle-mediated, exocytotic dopamine efflux. Measurement of intracellular Ca 2ϩ concentrations using fura-2/acetoxymethyl ester revealed that amphetamine increased intracellular Ca 2ϩ by a transporter-dependent mechanism. In amphetamine-pretreated cells, amphetamine elicited a greater increase in intracellular Ca 2ϩ ; this increase depended upon the presence of extracellular Ca 2ϩ and N-and L-type Ca 2ϩ channel activity. The enhanced amphetamine-induced dopamine efflux requires Ca 2ϩ /calmodulin kinase activity. In vehicle-treated cells, 1 M amphetamine inhibited the calmodulin kinase activity although it did not in amphetamine-pretreated cells. This study suggests that repeated intermittent amphetamine couples norepinephrine transporter activity and Ca 2ϩ signaling.
2ϩ is required for the detection of this enhancement in the rat. In this study, we examined the role of Ca 2ϩ and Ca 2ϩ channels in the enhanced amphetamine-induced dopamine efflux that develops in PC12 cells following repeated intermittent amphetamine. Repeated pretreatment of PC12 cells with 1 M amphetamine followed by a drug-free period increased amphetamine-induced efflux of dopamine compared with controls. The enhancement in amphetamine-induced dopamine efflux depended upon the presence of extracellular Ca 2ϩ and was inhibited by the blockade of N-type and L-type Ca 2ϩ channels. The enhanced dopamine efflux was not altered by tetanus toxin or reserpine, treatments that abrogate synaptic vesicle-mediated, exocytotic dopamine efflux. Measurement of intracellular Ca 2ϩ concentrations using fura-2/acetoxymethyl ester revealed that amphetamine increased intracellular Ca 2ϩ by a transporter-dependent mechanism. In amphetamine-pretreated cells, amphetamine elicited a greater increase in intracellular Ca 2ϩ ; this increase depended upon the presence of extracellular Ca 2ϩ and N-and L-type Ca 2ϩ channel activity. The enhanced amphetamine-induced dopamine efflux requires Ca 2ϩ /calmodulin kinase activity. In vehicle-treated cells, 1 M amphetamine inhibited the calmodulin kinase activity although it did not in amphetamine-pretreated cells. This study suggests that repeated intermittent amphetamine couples norepinephrine transporter activity and Ca 2ϩ signaling.
The locomotor, reinforcing, and salient incentive effects of the psychostimulant amphetamine are attributed, in part, to the ability of amphetamine to induce outward transport of dopamine through the dopamine transporter, DAT (Wise and Bozarth, 1987) . Repeated intermittent treatment with amphetamine leads to a long-lasting behavioral sensitization and persistent neuroadaptations (Robinson and Becker, 1986; White and Kalivas, 1998; Wolf, 1998) . Behavioral sensitization is induced by a direct action of amphetamine in the dopamine cell body area, the ventral tegmentum area (VTA) (Vezina, 1993) , but is expressed in the terminal areas (Robinson and Becker, 1986) such as the striatum and nucleus accumbens. Although the behavioral sensitization is elicited by the repeated amphetamine, other neurotransmitters and even growth factors influence its development and expression (Wolf, 1998; Flores and Stewart, 2000; Vanderschuren and Kalivas, 2000) .
One long-lasting neuroadaptation resulting from repeated intermittent amphetamine treatment in the rat is enhanced efflux of dopamine in response to a subsequent amphetamine challenge (Robinson and Becker, 1986) . This neuroadaptation develops later than the behavioral sensitization but is extremely persistent and thus could contribute to the endurance of sensitization. An interesting feature of this neuroadaptation is its dependence upon extracellular Ca 2ϩ (Pierce and Kalivas, 1997; Kantor et al., 1999) . Although amphetamine-induced outward transport does not normally require extracellular Ca 2ϩ , the enhancement in amphetamine-mediated dopamine efflux following repeated amphetamine requires extracellular Ca 2ϩ and is blocked by inhibitors of Ca 2ϩ /calmodulin-dependent protein kinase II (CaM kinase II) (Kantor et al., 1999) .
In the rat, this neuroadaptation is expressed in the terminal areas of striatum and nucleus accumbens but is initiated by amphetamine in the VTA (Vezina, 1993) . We have shown, however, that this neuroadaptation can be developed in cell lines containing monoamine transporters for which amphetamine is a substrate (Kantor et al., 2002) . Repeated intermittent treatment of rat pheochromocytoma PC12 cells or human neuroblastoma SH-SY5Y cells resulted in an enhancement in amphetamine-induced efflux of dopamine (Kantor et al., 2002) . The development of the neuroadaptation in the PC12 cells did not alter the number of monoamine transporters, the amount of dopamine in the cell, or the uptake of dopamine. There was a requirement for intermittent but not continuous dosage of amphetamine with several drug-free days following the repeated treatment. These experiments demonstrated that the inception of this neuroadaption did not require a complex intact neuroanatomy. Furthermore, we have demonstrated that the induction and expression of the neuroadaptation could be developed in the same cell.
It remains to be determined, however, whether the characteristics of the expression of the neuroadaption in the cells has the same Ca 2ϩ dependence as in the rat, that is, whether the enhanced amphetamine-induced efflux of dopamine is dependent upon extracellular Ca 2ϩ and CaM kinase II activity. The use of the PC12 cells gives us the advantage of measuring biochemical responses to amphetamine challenge in one cell type rather than the mixture of terminals and cell types in dopamine terminal areas of the rat. The PC12 cell has proven an ideal single-cell model in which to investigate molecular mechanisms of acute and repeated amphetamine. Measurement of release of endogenous dopamine, rather than norepinephrine, is suitable in the PC12 cells because they contain more dopamine than norepinephrine (Greene and Tischler, 1976) ; both dopamine and amphetamine are excellent substrates for the norepinephrine transporter (Wall et al., 1995) , and dopamine is readily released in PC12 cells in response to depolarization (Kittner et al., 1987) and amphetamine (Kantor et al., 2001) .
In this study, we examined whether the Ca 2ϩ requirement for the expression of the neuroadaption to repeated amphetamine, enhanced amphetamine-induced dopamine efflux, is the same in PC12 cells as in the rat. Using the PC12 cells, we further explored the ability of amphetamine to alter intracellular Ca 2ϩ by affecting Ca 2ϩ channel activity.
Materials and Methods
Cell Culture. PC12 cells were maintained in a 75-cm 2 tissue culture flask in growth medium composed of Dulbecco's modified Eagle's medium from Cambrex Bio Science Walkersville, Inc. (Walkersville, MD) supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 5% heat-inactivated horse serum, 2 mM L-glutamine, 100 g/ml streptomycin, and 100 units/ml penicillin (Invitrogen, Carlsbad, CA) and were incubated at 10% CO 2 . Cells (5 ϫ 10 4 cells/ml) were plated in a 75-cm 2 tissue culture flask at 10% CO 2 in the same growth medium. PC12 cells were treated with 1 M amphetamine (Sigma-Aldrich, St. Louis, MO) for 5 min a day for 5 days. After a 10-day drug-free period, cells were analyzed for amphetamine-stimulated dopamine efflux. The medium was changed every other day until cells were harvested for the experiments. For some experiments, cells were treated for 18 h with 10 nM tetanus toxin (Sandberg et al., 1989) .
Superfusion Assay. Cells were harvested by washing the flasks with Krebs-Ringer bicarbonate (KRB) buffer containing 125 mM NaCl, 2.7 mM KCl, 1.0 mM MgCl 2 , 1.2 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 10 mM glucose, 24.9 mM NaHCO 3 , and 0.25 mM ascorbic acid and oxygenated by 95% O 2 and 5% CO 2 for 1 h. Dopamine efflux was measured in the superfused cells by high-pressure liquid chromatography with electrochemical detection in response to 1 M amphetamine as described previously (Kantor et al., 2002) . All chambers were perfused with KRB buffer or drug for 30 min followed by a 2.5-min bolus KRB buffer or 1 M amphetamine with or without the drug. For some experiments, cells were perfused for 90 min with 50 nM reserpine before introduction of 1 M amphetamine.
[ 3 H]DA Uptake. PC12 cells were grown and harvested as discussed above. Cells (200 l at 1.2 mg/ml protein) were placed in tubes and equilibrated to 37°C. Uptake of either 50 nM or 1 M [ 3 H]dopamine into PC12 cells was measured as described previously (Kantor et al., 2001) .
Calcium Measurement. Intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) was measured in fura-2-loaded PC12 cells using dual-wavelength spectrofluorometry according to Fisher et al. (1989) . PC12 cells were harvested and resuspended in KRB buffer with and without 1.2 mM CaCl 2 to a protein concentration of 3 mg/ml. The pellet was resuspended in KRB buffer with and without added Ca 2ϩ . The cells were then incubated with 50 ⌴ fura-2/AM buffer for 15 min at 37°C, washed twice, and resuspended in KRB buffer. Fluorescence measurements were made on 1-ml aliquots of cells maintained at 37°C and constantly stirred. Changes in [Ca 2ϩ ] i were monitored as variations in the fluorescence ratio of the 340-to 380-nm excitation wavelength in a Shimadzu RF-5000 spectrofluorimeter. Calcium concentrations were calculated by the method of Grynkiewicz et al. (1985) . In some experiments, PC12 cells were preincubated for 10 min with 5 M nitrendipine or 1 M -conotoxin GVIA following loading of fura-2/AM.
CaM Kinase II Activity. Cells were homogenized in a buffer containing 50 mM PIPES pH 7.0, 1 mM EGTA, 10% glycerol, 2 mM dithiothreitol, 50 mM sodium fluoride, 10 mM sodium pyrophosphate, 1 mM sodium vanadate, and protease inhibitor cocktail. Homogenates were sonicated in a bath sonicator for 5 min at 4°C and then centrifuged for 20 min at 10,000g. Supernatants were assayed for CaM kinase II in a reaction mixture (50 l) containing 50 mM PIPES, pH 7.0, 15 mM MgCl 2 , 1 mM CaCl 2 or 5 mM EGTA, 0.5 g of calmodulin, 50 g of bovine serum albumin, and 10 M autocamtide as substrate. Reactions were initiated by addition of 50 M [␥-
32 P]ATP (1 Ci/mmol). Samples were incubated at 30°C for 1 min, and the reaction was stopped by adding 50 l of 10% trichloroacetic acid. The samples were centrifuged at 10,000g; 25 l of supernatant was spotted on P81 paper, washed with four changes of water, dried, and counted in a Beckman scintillation counter LS 5801 using Scintiverse. Specific activity is expressed as nanomoles of 32 P transferred to the substrate per minute per milligram of protein.
Statistics. Statistical significance was determined in most experiments using one-way ANOVA. Post hoc comparisons of data were made using the Tukey-Kramer multiple comparisons test. All calculations were performed using GraphPad 3.0.
Results

Ca
2؉ Requirement for Enhanced Amphetamine-Induced DA Efflux. As we reported previously (Kantor et al., 2002) , repeated intermittent treatment of the PC12 cells with 1 M amphetamine resulted in an enhanced efflux of dopamine to a subsequent challenge with 1 M amphetamine in the perfusion apparatus. Detection of the enhanced dopamine efflux, however, was contingent upon the presence of Ca 2ϩ in the KRB perfusion buffer (Fig. 1 ). When KRB buffer not containing CaCl 2 was perfused through amphetaminepretreated cells, the amount of dopamine efflux was the same as that of vehicle-treated cells. The requirement of extracellular Ca 2ϩ for the expression of the enhanced amphetamineinduced dopamine efflux mimics the finding in the rat (Kantor et al., 1999). As shown in Kantor et al. (2002) . Effect of Ca 2؉ Channel Blockers on the Expression of Enhanced Amphetamine-Induced DA Efflux after Repeated Intermittent Amphetamine. The requirement for extracellular Ca 2ϩ for detection of the enhanced amphetamine-induced dopamine efflux suggested that Ca 2ϩ could be entering the cell through Ca 2ϩ channels. PC12 cells contain both N-and L-type Ca 2ϩ channels (Taylor and Peers, 1999) . To assess that possibility, cells were perfused with either 5 M nifedipine, an L-type Ca 2ϩ channel blocker, or 1 M -conotoxin GVIA, an N-type Ca 2ϩ channel blocker, for 30 min prior to the bolus of 1 M amphetamine. As shown in Fig. 2 , both nifedipine and -conotoxin GVIA blocked the enhancement in dopamine efflux in response to amphetamine from PC12 cells that were pretreated with repeated intermittent amphetamine.
Evaluation of the Role of Vesicular Storage on the Expression of Enhanced
Amphetamine-Induced DA Efflux after Repeated Intermittent Amphetamine. Entrance of Ca 2ϩ through both L-and N-type Ca 2ϩ channels leads to exocytotic neurotransmitter release in PC12 cells (Taylor and Peers, 1999) . Ca 2ϩ entry through the Ca 2ϩ channels could elicit release of dopamine from vesicular stores, which would account for the enhancement in dopamine efflux in response to amphetamine. To assess this possibility, we pretreated the cells with two agents known to block vesicular neurotransmitter release, tetanus toxin and reserpine. Tetanus toxin inhibits vesicular release by the cleavage of synaptobrevin (Link et al., 1992) . Reserpine blocks uptake of dopamine and norepinephrine into the vesicles leading to a profound depletion of catecholamines. Although reserpine blocks vesicular monoamine release it does not affect DATmediated dopamine efflux (Chiueh and Moore, 1975) . Reserpine (50 nM) was perfused through vehicle-or amphetaminepretreated PC12 cells for 90 min before the challenge with 1 M amphetamine. This treatment reduced the dopamine content of the vehicle-treated cells by 88 Ϯ 4% (n ϭ 6) and the dopamine content of amphetamine-pretreated cells by 93 Ϯ 2% (n ϭ 6). Vehicle-or amphetamine-pretreated cells were incubated with 10 nM tetanus toxin for 18 h on the 9th drug-free day (day 14 of total treatment). The data in Fig. 3 demonstrate that neither the depletion of vesicular dopamine stores by reserpine nor the blockade of exocytosis by tetanus toxin altered the expression of the enhanced dopamine efflux in response to amphetamine. The effectiveness of the tetanus toxin treatment in blocking exocytotic dopamine release was assessed by measuring the dopamine release in response to 50 mM KCl. There was no dopamine efflux in response to 50 mM KCl in the tetanus toxin-treated cells. In the amphet- is required for the detection of the enhanced amphetamine-induced dopamine efflux following repeated amphetamine in PC12 cells. PC12 cells were treated with repeated vehicle (Veh) or 1 M amphetamine (AMPH) for 5 min/day for 5 days followed by 10 drug-free days, harvested, and perfused as described under Materials and Methods. Cells were washed with KRB buffer prepared with (ϩCa 2ϩ ) or without (ϪCa 2ϩ ) 1.2 mM CaCl 2 for 1 h, and fractions containing basal dopamine were collected. Amphetamine (1 M) was administered for 2.5 min and reached the cells at fraction 9 (shown by arrow). Dopamine in the samples was analyzed by high-pressure liquid chromatography with electrochemical detection. Results are given in picomoles of dopamine per milligram of protein in each fraction (500-l eluent Ϯ S.E.M., n ϭ 4). ‫,ء‬ p Ͻ 0.02 by two-tailed Student's t test for fraction 10. 2 . Blockade of N-and L-type Ca 2ϩ channels specifically blocks the enhanced amphetamine-induced dopamine efflux in amphetamine-pretreated cells. PC12 cells were treated with repeated vehicle (VEH) or amphetamine (AMPH), harvested, and perfused as described in the legend to Fig. 1 and under Materials and Methods. Cells were perfused for 30 min with KRB buffer alone or KRB buffer containing 1 M -conotoxin (Cntx), an N-type Ca 2ϩ channel blocker, or 5 M nifedipine (Nif), an L-type Ca 2ϩ channel blocker. All cells were then perfused with 1 M amphetamine for 2.5 min followed by a return to KRB buffer with or without drugs. Results are given as amphetamine-induced dopamine efflux (in pmol/mg of protein Ϯ S.E.M.), n ϭ 3 to 5. Baseline values (in pmol/mg of protein Ϯ S.E.M.) for VEH, VEH-Cntx, and VEH-Nif were: 2.9 Ϯ 0.8, 3.5 Ϯ 0.6, and 2.1 Ϯ 0.6; baseline values (in pmol/mg of protein Ϯ S.E.M.) for AMPH, AMPH-Cntx, and AMPH-Nif were: 5.3 Ϯ 1, 9.2 Ϯ 2, and 3.0 Ϯ 1.0. ANOVA, p ϭ 0.0002; in post hoc Bonferroni testing, ‫,ء‬ p Ͻ 0.001 compared with VEH-KRB and ‫,ءء‬ p Ͻ 0.05 compared with AMPH-KRB.
amine-pretreated cells, KCl-stimulated dopamine release was 15.4 Ϯ 4-fold over baseline in cells not treated with tetanus toxin and 1.25 Ϯ 0.2-fold over baseline in cells that were treated with tetanus toxin (n ϭ 4). The treatment with tetanus toxin did not change the total dopamine in the cells. Dopamine content (in nanomoles per milligram of protein Ϯ S.E.M.) in vehicle-pretreated cells given vehicle or tetanus toxin on day 14 was 2.29 Ϯ 0.3 and 2.28 Ϯ 0.4, respectively (n ϭ 6). Dopamine content (in nanomoles per milligram of protein Ϯ S.E.M.) in amphetamine-pretreated cells given vehicle or tetanus toxin on day 14 was 2.45 Ϯ 0.5 and 2.49 Ϯ 0.3, respectively (n ϭ 6).
Ability of Amphetamine to Increase Intracellular Ca
2؉ in Cells Pretreated with Repeated Intermittent Vehicle or Amphetamine. The requirement of extracellular Ca 2ϩ for the expression of the enhanced dopamine efflux in the presence of amphetamine suggests that amphetamine stimulated the entrance of Ca 2ϩ into the cell. To determine whether the amphetamine challenge increased intracellular Ca 2ϩ , PC12 cells were pretreated with repeated intermittent vehicle or amphetamine, followed by 10 drug-free days, and then loaded with fura-2/AM to measure intracellular Ca 2ϩ . Cells were suspended in KRB buffer made with and without CaCl 2 . The data in Fig. 4 demonstrate that a challenge dose of 1 M amphetamine increased intracellular Ca 2ϩ in vehicle-pretreated PC12 cells, and that increase was not dependent upon the presence of extracellular Ca 2ϩ . The response to 1 M bradykinin is also shown. Amphetamine, at 1 M, elicited a significantly greater increase in intracellular Ca 2ϩ in the PC12 cells that had been pretreated with repeated amphetamine compared with those pretreated with vehicle (Fig. 4) . The intracellular Ca 2ϩ rose rather rapidly following administration of amphetamine (Fig. 4, inset) , then maintained a plateau. It did not return to baseline values within 5 min. As shown in Fig. 4 , the enhanced ability of amphetamine to increase intracellular Ca 2ϩ required the presence of extracellular Ca 2ϩ . The increase in intracellular Ca 2ϩ in response to bradykinin, however, was unaltered by pretreatment of PC12 cells with repeated intermittent amphetamine. Thus, the enhancement in response was specific for amphetamine. The ability of amphetamine to elicit the increase in intracellular Ca 2ϩ was blocked by desipramine, demonstrating the involvement of NET. In the presence of 10 M desipramine, with or without Ca 2ϩ in the KRB buffer, intracellular Ca 2ϩ measurements after administration of 1 M amphetamine were 36.1 Ϯ 4.8 nM and 25.5 Ϯ 2.3 nM in vehicle-and amphetamine-pretreated cells, respectively (n ϭ 6). These values were not different from baseline values (Fig. 4) . Fig. 3 . Tetanus toxin and reserpine do not alter the enhanced amphetamine-induced dopamine efflux in amphetamine-pretreated cells. PC12 cells were treated with repeated vehicle (VEH) or amphetamine (AMPH). Cells were treated with vehicle or 10 nM tetanus toxin on day 14 or were perfused with vehicle or 50 nM reserpine for 90 min on day 15 (the 10th drug-free day) as described under Materials and Methods. Following perfusion with either KRB buffer or reserpine, 1 M amphetamine was given for 2.5 min followed by a return to KRB buffer. Results are given in -fold baseline Ϯ S.E.M. Baseline values for VEH, VEH-tetanus toxin, and VEH-reserpine in picomoles per milligram of protein were: 2.8 Ϯ 0.9, 3.9 Ϯ 1.0, and 4.2 Ϯ 1.9, respectively; baseline values for AMPH, AMPHtetanus toxin, and AMPH-reserpine were: 3.0 Ϯ 0.8, 1.7 Ϯ 0.5, and 1.8 Ϯ 0.6, respectively; n ϭ 6 to 8. ANOVA was calculated by Kruskal-Wallis nonparametric test, p Ͻ 0.002. In post hoc Dunn's multiple comparison testing, ‫,ء‬ p Ͻ 0.05 compared with each corresponding VEH value. 
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To determine whether amphetamine was activating L-or N-type Ca 2ϩ channels to increase the intracellular Ca 2ϩ , we incubated the cells with either 5 M nifedipine or 1 M -conotoxin GVIA before amphetamine was added. These treatments did not change baseline Ca 2ϩ measurements. As shown in Fig. 5 , both -conotoxin GVIA and nifedipine inhibited the enhanced portion of the amphetamine-induced increase in intracellular Ca 2ϩ in cells that had been pretreated with amphetamine. On the contrary, neither Ca 2ϩ channel blocker affected the ability of amphetamine to increase intracellular Ca 2ϩ in vehicle-pretreated cells. Nifedipine and -conotoxin GVIA reduced the amphetamine-mediated influx of Ca 2ϩ in amphetamine-pretreated PC12 cells only to the level of vehicle-pretreated cells.
CaM Kinase Activity Is Required for the Enhanced Amphetamine-Induced Efflux following Repeated Intermittent Amphetamine. The role of a Ca 2ϩ /CaM-dependent protein kinase was examined by perfusing the cells for 30 min with 10 M KN-93, a selective inhibitor of CaM kinase II. The data of Fig. 6 demonstrate that KN-93 reduced the ability of amphetamine to release dopamine, but only to the level of efflux exhibited in the vehicle-treated cells. Thus, Ca 2ϩ and CaM played a role only in the enhanced portion of the amphetamine-induced dopamine efflux following repeated intermittent amphetamine treatment. To further explore whether the Ca 2ϩ /CaM-sensitive component of amphetamine-induced dopamine efflux could be attributed to vesicular storage, we examined whether KN-93 could inhibit the enhanced amphetamine-stimulated efflux following reserpine treatment in amphetamine-pretreated cells. In this set of experiments, dopamine efflux in response to 3 M amphetamine was 1.5-fold baseline Ϯ 0.1 in vehicle-pretreated cells and 2.3 Ϯ 0.2 in amphetamine-pretreated cells (n ϭ 4, p Ͻ 0.05). Following 90 min of 50 nM reserpine, amphetamine-stimulated dopamine efflux was unchanged (1.5 Ϯ 0.2 vehicle pretreated and 2.5 Ϯ 0.3 amphetamine pretreated, n ϭ 4, p Ͻ 0.05). Following the reserpine pretreatment, KN-93 was still able to inhibit the amphetaminestimulated dopamine efflux in the amphetamine-pretreated PC12 cells (1.39 Ϯ 0.04, p Ͻ 0.05 compared with amphetamine and reserpine pretreatment). KN-93 had no effect on amphetamine-stimulated dopamine efflux in vehicle-or vehicle-and reserpine-pretreated PC12 cells. Therefore it is unlikely that the CaM kinase II-sensitive portion of the amphetamine-stimulated dopamine efflux following repeated amphetamine depends upon synaptic vesicular storage. This result is reminiscent of that found in the rat. Reserpine pretreatment did not alter the ability of KN-93 to inhibit amphetamine-stimulated dopamine release in the striatum from amphetamine-pretreated rats (Kantor et al., 1999) .
Dopamine efflux in response to 1 M amphetamine was abolished by perfusion with a protein kinase C inhibitor, chelerythrine, in both vehicle-and amphetamine-pretreated cells (Fig. 6) . We have shown previously that preincubation with protein kinase C inhibitors block amphetamine-induced dopamine efflux through NET in PC12 cells (Kantor et al., 2001) .
CaM Kinase Activity following Repeated Intermittent Amphetamine. We examined whether the greater flux of Ca 2ϩ into the cell in response to an amphetamine challenge in the amphetamine-pretreated cells would result in an enhancement of CaM kinase activity. Following the repeated intermittent vehicle or amphetamine pretreatment and the drug-free period, cells were incubated for 2.5 min with vehicle or 1 M amphetamine in KRB buffer. As shown in Table  2 , the challenge with 1 M amphetamine significantly decreased CaM kinase activity in the PC12 cells treated with repeated intermittent amphetamine. There was no difference in activity between the cells pretreated with vehicle or amphetamine in the absence of amphetamine challenge. In contrast to the vehicle-pretreated cells, however, there was no change in CaM kinase activity following amphetamine chal- lenge in the amphetamine-pretreated cells. We also performed the experiment in the presence of 1 M sulpiride, since it was reported that dopamine D2-like activity could inhibit striatal CaM kinase II activity (Hou et al., 2001) , and PC12 cells have D2 receptors. Preincubation with sulpiride did not affect the ability of amphetamine to inhibit the CaM kinase II activity in the PC12 cells. The CaM kinase activity in all groups was unaltered by sulpiride. Activity in the absence of Ca 2ϩ or CaM represented only about 4 to 5% of the total activity, and it did not change with treatment. The kinase activity is likely due to CaM kinase II activity. Immunoblot of PC12 cells with an antibody to pan CaM kinase II gave a band at 50 kDa that migrated at the same spot as that from rat hippocampus (data not shown).
Discussion
In this study, we have demonstrated that the enhanced amphetamine-induced outward transport of dopamine following repeated intermittent treatment of PC12 cells is dependent on extracellular Ca 2ϩ and CaM kinase II. These characteristics are evocative of those found in rat striatum and nucleus accumbens following repeated intermittent stimulants (Pierce and Kalivas, 1997; Kantor et al., 1999) . Moreover, using the advantage of PC12 cells, we have demonstrated that an amphetamine challenge promotes the influx of extracellular Ca 2ϩ through N-and L-type Ca 2ϩ channels into cells that received repeated intermittent amphetamine.
By using the PC12 cell, we have demonstrated both induction and expression of a neuroadaptation resulting from repeated intermittent amphetamine in the same cells. In the rat, behavioral sensitization and concomitant neuroadaptations are induced by an action of amphetamine at the dopamine cell body area and expressed in the terminals (Vezina, 1993) , which are anatomically distanced from the cell body. PC12 cells, however, although not neurons, contain elements present in catecholaminergic cells that could be important for the development of this neuroadaptation: enzymes for catecholamine synthesis and metabolism, including tyrosine hydroxylase, elements for storage of catecholamines, the densecore granules with a vesicular monoamine transporter (Greene and Tischler, 1976) , and a plasmalemmal catecholamine transporter (NET) for inward and outward catecholamine transport (Bruss et al., 1997) . In addition, the cells contain a CaM kinase activity that is required for the manifestation of the particular neuroadaptation being investigated in this study (Enslen and Soderling, 1994) . Although amphetamine acts at the dopamine transporter DAT, in rat VTA, NET shares many important characteristics with DAT. The two proteins are Na ϩ /Cl Ϫ -dependent transporters that share over 70% homology (Giros and Caron, 1993) . They also share many of the same substrates, including dopamine and amphetamine (Wall et al., 1995) and blockers, such as cocaine (Buck and Amara, 1995) . Basic aspects of their regulation, such as sensitivity to regulation by protein kinase C, are the same with the two transporters (Kantor et al., 2001 ). Therefore it is not unreasonable that repeated intermittent amphetamine would similarly affect the functions of DAT and NET.
The reason for the Ca 2ϩ sensitivity of the enhanced amphetamine-mediated outward transport of dopamine is unknown. It could be due to a modification of transporter function or possibly an increase in supply of dopamine to the transporter. If it is a modification of transporter function, it is not one that is reflected in a change in uptake. There was neither a change in [ 3 H]dopamine uptake between vehicleand amphetamine-pretreated cells nor was there a Ca 2ϩ sensitivity to the uptake process. The lack of change in [ 3 H]dopamine uptake and in whole cell [ 3 H]nisoxetine binding (Kantor et al., 2002) suggests that there is not an increase in surface NET. Although one would logically expect an alteration in efflux to correspond with a change in uptake, the transporter can be asymmetrically regulated (Sitte et al., 1998; Khoshbouei et al., 2004) . We recently demonstrated that uptake and efflux through the dopamine transporter have different structural determinants and can be independently regulated . Furthermore, there are a number of proteins that bind to the catecholamine transporters (Zahniser and Doolen, 2001 ). For instance, phosphorylation of a protein associated with the transporter could alter its function by altering a cytoskeletal interaction. A change in binding proteins could also alter the conformation of the transporter (Zahniser and Doolen, 2001 ). An increased supply of dopamine to the transporter appears unlikely. The lack of effect of reserpine pretreatment suggests that compromised vesicular function resulting in enhanced cytosolic dopamine is not an explanation for the enhanced NET-mediated efflux. Similarly, reserpine treatment did not diminish the enhancement in amphetamineinduced dopamine efflux in rat striatum following repeated treatment of rats with amphetamine (Kantor et al., 1999) . The repeated amphetamine treatment did not increase the total dopamine in the cell (Kantor et al., 2002) , the tyrosine hydroxylase content, or phosphorylation at sites known to increase the enzyme activity in the PC12 cell (Y. H. Park and J. A. Haycock, unpublished data) . Although the Ca 2ϩ requirement for the enhanced amphetamine-induced efflux suggests that vesicular dopamine release could be triggered, this possibility is unlikely because neither tetanus toxin pretreatment nor reserpine altered the enhanced response to amphetamine. Therefore, despite the apparent involvement of extracellular Ca 2ϩ as well as L-and N-type calcium channels, vesicular release of dopamine or another vesicularbound neurotransmitter does not appear to be involved in the effect. Amphetamine, however, can depolarize the membrane (Kahlig et al., 2004) . Repeated treatment with amphetamine could alter the membrane potential to make the transporter more responsive to amphetamine. Additionally, increased Ca 2ϩ , due to a depolarizing pulse, has been demonstrated to increase trafficking of GABA transporters to the cell surface (Deken et al., 2003) . We are presently examining whether a Ca 2ϩ -dependent increased rate of transporter trafficking can explain our results.
Our results suggest that following amphetamine pretreatment, amphetamine acts to enhance L-or N-type Ca 2ϩ channel activity to promote flux of Ca 2ϩ into the cell. Thus, the consequence of the repeated intermittent amphetamine pretreatment is an involvement of Ca 2ϩ channels in the enhancement of two NET-mediated activities, dopamine efflux and Ca 2ϩ influx. Amphetamine elicited an increase in intracellular Ca 2ϩ even in vehicle-pretreated PC12 cells that was independent of Ca 2ϩ channels or extracellular Ca 2ϩ . We have demonstrated that amphetamine elicits a cocaine-and thapsigargin-sensitive influx of Ca 2ϩ in HEK 293 cells stably transfected with hDAT . Another mechanism by which amphetamine could increase intracellular Ca 2ϩ is through Na ϩ /Ca 2ϩ exchange. Giambalvo (2004) presented evidence suggesting that amphetamine, through an increase in intracellular pH, could increase a Na ϩ /Ca 2ϩ exchange activity in rat striatum, which is required for amphetamine to increase PKC activity. An activation of PKC by amphetamine could alter Ca 2ϩ channel activity. N-and Ltype Ca 2ϩ channels are substrates for PKC (Catterall, 2000) . PKC activation has been shown to enhance Ca 2ϩ currents through both L-and N-type Ca 2ϩ channels (Barrett and Rittenhouse, 2000) . We, and others, have shown that amphetamine can activate PKC in rat striatum and PC12 cells (Iwata et al., 1997b; Giambalvo, 2003; Park et al., 2003) and that phosphorylation of some PKC substrates can increase following repeated intermittent amphetamine (Iwata et al., 1997a) . Specific forms of N-type Ca 2ϩ channel subunits are also substrates for CaM kinase II (Catterall, 2000) . This involvement of L-and N-type Ca 2ϩ channels in a stimulantinduced neuroadaptation is reminiscent of the results of Pierce and Kalivas (1997) who found that behavioral sensitization to repeated cocaine was blocked by both N-and L-type Ca 2ϩ channel blockers. We were not able to demonstrate a direct activation of CaM kinase II by amphetamine in either vehicle-or amphetaminepretreated PC12 cells. In fact, incubation of vehicle-pretreated PC12 cells with 1 M amphetamine for only 2.5 min inhibited CaM kinase II activity. This inhibition mirrors the attenuating effect of a peripheral injection of amphetamine on CaM kinase II activity in several rat brain areas including nucleus accumbens and striatum (Suemaru et al., 2000) . CaM kinase II activity in amphetamine-pretreated cells following the 10 drug-free days was no different than the activity from the vehicle-treated cells. Moreover, an amphetamine challenge no longer inhibited the CaM kinase II activity. The lack of acute inhibition of CaM kinase II by amphetamine in the cells that had been pretreated with amphetamine suggests that the inhibitory process is no longer operable or that some portion of the enzyme activity is increasing to counterbalance the decrease. We reported an increase in CaM kinase II activity in striatal synaptosomes following treatment of rats with repeated intermittent amphetamine (Iwata et al., 1997a) . Our present data may resemble those of Suemaru et al. (2000) more than the synaptosomal data because we are using cells containing a wider variety of regulatory elements than striatal dopaminergic synaptosomes used in our previous study, which are primarily presynaptic structures. Suemaru et al. (2000) used an extract that would contain preand postsynaptic elements and found that the amphetaminemediated inhibition of CaM kinase II was mediated by an activation of D1 dopamine receptors. It is possible that amphetamine is altering the activation of a receptor in PC12 cells to inhibit CaM kinase II, although our results suggest that it would not be the dopamine D2 receptor. Similarly, amphetamine could alter the activity of a protein phosphatase, which rapidly alters CaM kinase II activity.
In summary, we have documented that integral characteristics of one neuroadaptation that occurs in brain, enhanced amphetamine-induced dopamine efflux through DAT, can be reproduced in a PC12 cell containing NET. The integral characteristics are the dependence upon extracellular Ca 2ϩ and involvement of CaM kinase II and Ca 2ϩ channels. Moreover, we have made the original finding that repeated treatment with amphetamine results in an activation of N-and L-type Ca 2ϩ channels by amphetamine, which mediates the entry of extracellular Ca 2ϩ into the cell. The increased cellular Ca 2ϩ appears to activate CaM kinase II, which mediates the enhanced amphetamine-induced efflux through the norepinephrine transporter.
